Venu Babu Ganipisetty

This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Arrien Pharmaceuticals LLC. Active years: 2016-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Venu Babu Ganipisetty. Retrieved from https://idiyas.com/inventor/venu-babu-ganipisetty

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3

% Patents Active = 100.0

CIPO Patents = 1

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)

Location History:

Hyderabad, IN (2016)
Andhra Pradesh, IN (2018)

Company Filing History:

3 out of 14

Arrien Pharmaceuticals LLC

patents

Years Active: 2016-2018

Loading Chart...

3 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9951062 - Substituted 1 H-pyrrolo [2, 3-b] pyridine and 1 H-pyrazolo [3, 4-b] pyridine derivatives as salt inducible kinase 2 (SIK2) inhibitors (2018-04-24),

2. 9890153 - Substituted 1H-pyrrolo [2, 3-b] pyridine and 1H-pyrazolo [3, 4-b] pyridine derivatives as salt inducible kinase 2 (SIK2) inhibitors (2018-02-13),

3. 9260426 - Substituted 1H-pyrrolo [2, 3-b] pyridine and 1H-pyrazolo [3, 4-b] pyridine derivatives as salt inducible kinase 2 (SIK2) inhibitors (2016-02-16),

Title: **Innovative Contributions of Venu Babu Ganipisetty in Pharmaceutical Chemistry**

Introduction

Venu Babu Ganipisetty, an accomplished inventor based in Andhra Pradesh, India, has made significant strides in the field of pharmaceutical chemistry. With three patents to his name, his innovative research focuses on developing compounds that target critical health issues, showcasing his commitment to advancing medical science.

Latest Patents

Ganipisetty's latest patents include groundbreaking work on substituted 1H-pyrrolo [2, 3-b] pyridine and 1H-pyrazolo [3, 4-b] pyridine derivatives. These compounds serve as salt inducible kinase 2 (SIK2) inhibitors, with potential applications in treating a range of severe diseases and disorders, including cancer, stroke, cardiovascular conditions, obesity, and type II diabetes. His patents detail the synthesis and use of these compounds in pharmaceutical compositions, highlighting their significance as therapeutic agents.

Career Highlights

Currently, Venu Babu Ganipisetty works at Arrien Pharmaceuticals LLC, where he continues to push the boundaries of pharmaceutical innovation. His dedication to research and development underscores his role as an influential figure in the industry and contributes to the ongoing advancement of treatments for various health concerns.

Collaborations

Ganipisetty collaborates with several esteemed professionals in his field, including Hariprasad Vankayalapati and Venkatakrishnareddy Yerramreddy. These partnerships not only enhance the quality of research but also foster a collaborative environment that promotes innovative solutions in drug development.

Conclusion

Venu Babu Ganipisetty's contributions to pharmaceutical chemistry underscore the importance of innovation in addressing complex health issues. His work epitomizes the role of dedicated inventors in creating solutions that can potentially improve countless lives. With his continued efforts in research and collaboration, Ganipisetty is poised to make an even greater impact in the field of medicine.

Profile summary based on public USPTO records.